Followers | 26 |
Posts | 2330 |
Boards Moderated | 0 |
Alias Born | 03/02/2017 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 04, 2018 10:52:48 PM
SANDUSKY, Ohio, Nov. 21, 2017 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC:PAOG), a physicians practice management company focused on the proper use of cannabis for treatment of chronic and terminal patients, announces today that, in partnership with its sister company, Rising BioSciences, Inc. (OTC:RSII), it will be holding classes in its Ohio facilities for the general public that focus on proper usage for Naloxone.
Naloxone is a medication designed to rapidly reverse opioid overdose and is often sold under trade names Narcan® and Evzio®. Classes will be held in the Company’s Sandusky, Toledo, and Parma locations. In collaboration with Rising Biosciences, PAO Group's Alternative Medicine Centers will make Naloxone available at little to no cost for the people that participate in the events.
“In line with our core mission, PAO Group and its associates are doing everything we can to implement responsible use of Cannabis and innovative medicine to mitigate the grip that opiates currently have on our country,” states Christopher Will, Vice President of Operations. “The classes are something we’ve added to educate the community while further raising awareness of the opioid epidemic affecting so many Americans and their loved ones.”
In addition to the Naloxone classes, PAO is thrilled to announce that it has received Letters of Intent from two (2) of the applicants for the thirty (30) state approved cannabis dispensaries in the State of Ohio, to lease buildings from PAO Group, Inc. for operations.
“We continue to grow the company with an assertive strategy designed to put the patients first,” states Will. “We have posted 3rd Quarter filings with OTC Markets and are very pleased with the continued success. This quarter saw close to $200,000 in revenues, and we expect cumulative increase in revenues as we continue to expand our facilities and offerings.”
Dates and Times for the Naloxone classes will be announced via press release and social media channels once confirmed.
Visit our website at: www.PAO.Group ?Contact us: info@pao.group or 1-888-PAO-Group "Like" and "Share"
PAO Group on Facebook/paogroupinc and follow us on Twitter @paogroup?
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM